Qwadra Acquires Podoprinter to Revolutionize Digital Podiatry

The Eqwal Group, through its digital branch Qwadra, today announces the acquisition of Podoprinter, pioneer of continuous belt 3D printing technology for custom plantar orthoses.

For more than four years, Qwadra and Podoprinter have collaborated closely to drive the digitization of podiatry practices around the world. Their partnership has enabled the development and implementation of innovative solutions that combine digital workflows with advanced additive manufacturing, transforming how podiatric care is delivered. With this acquisition, that collaboration deepens: Podoprinter’s research, development, and industrialization teams will play a pivotal role in strengthening Qwadra’s long-term strategic plan and accelerating the introduction of next-generation 3D printers and specialized materials tailored specifically to the needs of foot care professionals.

“Welcoming Podoprinter’s talent is an exceptional opportunity to speed up the digital transformation of podiatry,” says Luc Boronat, CEO of Qwadra. “By bringing together Arkad’s advanced podiatry software expertise with Podoprinter’s proven industrial know-how, we can provide foot care practitioners with a seamless, fast, and environmentally responsible end-to-end solution. Our integrated platform will empower clinicians to prescribe, design, and manufacture custom orthotics more efficiently than ever before, while minimizing waste and ecological impact.”

Echoing this enthusiasm, Ruud Rouleaux, CEO of Podoprinter, states, “I am delighted with this integration and extremely excited to provide our customers with guaranteed service continuity plus an ever-expanded portfolio of cutting-edge technologies. By joining Qwadra, we merge our continuous 3D printing expertise with the full capabilities of the Arkad podiatry ecosystem. This synergy will enable us to set new industry benchmarks for digital podiatry, ensuring our clients continue to benefit from the quality, innovation, and responsiveness that have been hallmarks of both organizations. Together, we are uniquely positioned to shape the future of podiatric care and deliver meaningful advancements for practitioners and patients worldwide.”